Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two Phase 1 trials

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2017)

引用 0|浏览23
暂无评分
关键词
immunotherapy,cancer,32nd annual meeting,pre-conference
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要